Fatigue is common after stroke, but there’s currently a lack of treatment available for fatigue after stroke. This research will create a fatigue management programme designed to support stroke survivors to self-manage their fatigue.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
What maintains stroke survivors’ continued use of self-managed computer therapy for aphasia?
Film-maker Lotje Sodderland (‘My Beautiful Broken Brain’; ‘Can You Rebuild My Brain?’) directed our Rebuilding Lives campaign. Lotje tells us what the campaign means to her.
The Stroke Association is launching bespoke wedding favours to help you give back on your special day. Sign up now to find out more.
Our report ‘Current, future and avoidable costs of stroke in the UK’ suggests that investing in stroke research today could lead to a significant reduction in the burden of stroke in the future.
We need your support to continue to invest in research that will help to save lives and enable stroke survivors to make the best possible recovery.
Our Government’s current stroke strategy is coming to an end in 2017 and there is no plan to introduce a new one. In this edition of Stroke News, we tell you how we're calling on Government to keep stroke on its agenda. Sign our petition today and help create A New Era for Stroke.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
The Stroke Association is also a member of the Stroke Alliance for Europe (SAFE), a network of organisations that champion the voices of those affected by stroke. SAFE is currently involved in several European research projects. You can find out more about these projects hoping to improve treatment for stroke patients.